Excelsior Biopharma Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 1,443.661 million compared to TWD 1,540.064 million a year ago. Operating income was TWD 41.477 million compared to TWD 86.779 million a year ago. Net income was TWD 35.300 million compared to TWD 71.012 million a year ago. Basic earnings per share from continuing operations was TWD 0.76 compared to TWD 1.52 a year ago. Diluted earnings per share from continuing operations was TWD 0.73 compared to TWD 1.52 a year ago.